Bridgebio Oncology TherapeutBBOT
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 52 institutions reported holding Bridgebio Oncology Therapeut (BBOT) in their 13F filings, up 10 from Q3 2025. 14 opened new positions and 4 sold out. The largest holders were Cormorant Asset Management, LP ($223.8M), Deerfield Management Company, L.P. ($61.2M) and Omega Fund Management, LLC ($41.2M). 4 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bridgebio Oncology Therapeut
- CUSIP
- 107924102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $7.5M |
| Exits | 4 | $5.4M |
All 13F filers, Q3 2025 → Q4 2025: 2,387,698 shares bought and 1,303,017 shares sold, net +1,084,681 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 52 holders
| Cormorant Asset Management, LP | 12.69% | No change | 17,878,594 | $223.8M |
| Deerfield Management Company, L.P. | 0.89% | No change | 4,885,446 | $61.2M |
| Omega Fund Management, LLC | 14.37% | No change | 3,289,661 | $41.2M |
| Wellington Management Group LLP | 0.01% | Reduce -1.8% | 2,907,003 | $36.4M |
| EcoR1 Capital, LLC | 1.62% | No change | 2,823,126 | $35.3M |
| Alphabet Inc. | 1.37% | No change | 2,823,126 | $35.3M |
| Enavate Sciences Gp, LLC | 6.49% | No change | 2,626,946 | $32.9M |
| Citadel Advisors | 0.02% | Reduce -0.3% | 2,530,324 | $31.7M |
| Paradigm Biocapital Advisors LP | 0.76% | Add +21.2% | 2,261,749 | $28.3M |
| BlackRock, Inc. | 0.00% | Add +1.8% | 2,084,837 | $26.1M |
| Novo Holdings A/S | 1.91% | No change | 1,961,317 | $24.6M |
| Laurion Capital Management LP | 1.30% | Add +40.1% | 1,464,938 | $18.3M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | Reduce -5.9% | 1,400,000 | $17.5M |
| Eventide Asset Management, LLC | 0.21% | No change | 1,082,362 | $13.4M |
| Octagon Capital Advisors LP | 1.64% | No change | 1,043,110 | $13.1M |
| Armistice Capital, LLC | 0.31% | Add +142.7% | 1,000,000 | $12.5M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -9.3% | 803,134 | $10.1M |
| Vanguard Group Inc. | 0.00% | Add +22.2% | 791,095 | $9.9M |
| Aisling Capital Management LP | 1.48% | No change | 564,625 | $7.1M |
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 561,987 | $7.0M |
| Casdin Capital, LLC | 0.22% | No change | 282,312 | $3.5M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -0.1% | 279,046 | $3.5M |
| Millennium Management | 0.00% | Reduce -34.7% | 241,415 | $3.0M |
| FMR LLC | 0.00% | Add +48.3% | 240,300 | $3.0M |
| HighVista Strategies LLC | 0.74% | New | 229,263 | $2.9M |
| ADAR1 Capital Management, LLC | 0.21% | Reduce -54.9% | 226,248 | $2.8M |
| Ikarian Capital, LLC | 0.36% | Reduce -10.2% | 220,231 | $2.8M |
| State Street Corp. | 0.00% | Add +23.5% | 218,278 | $2.7M |
| Sio Capital Management, LLC | 0.27% | No change | 130,628 | $1.6M |
| TD Asset Management Inc | 0.00% | Reduce -9.9% | 117,150 | $1.5M |
| Woodline Partners LP | 0.01% | No change | 103,707 | $1.3M |
| Moore Capital Management, LP | 0.03% | No change | 100,000 | $1.3M |
| Goldman Sachs Group Inc. | 0.00% | New | 94,651 | $1.2M |
| UBS Group AG | 0.00% | Add +78.8% | 93,369 | $1.2M |
| Stempoint Capital LP | 0.19% | Reduce -53.6% | 86,517 | $1.1M |
| Renaissance Technologies | 0.00% | New | 74,300 | $930K |
| Boothbay Fund Management, LLC | 0.02% | Reduce -30.6% | 67,034 | $839K |
| Northern Trust Corp. | 0.00% | Reduce -39.5% | 58,034 | $727K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 54,192 | $670K |
| Qube Research & Technologies Ltd | 0.00% | New | 35,952 | $450K |
| XTX Topco Ltd | 0.01% | Add +22.4% | 28,633 | $358K |
| BNP Paribas Financial Markets | 0.00% | New | 26,472 | $331K |
| BIT Capital GmbH | 0.01% | New | 25,000 | $313K |
| Point72 Asset Management | 0.00% | New | 23,584 | $295K |
| Morgan Stanley | 0.00% | Add +1566.9% | 14,352 | $180K |
| Quadrature Capital Ltd | 0.00% | New | 12,922 | $162K |
| Squarepoint Ops LLC | 0.00% | New | 11,515 | $144K |
| Persistent Asset Partners Ltd | 0.05% | New | 8,585 | $107K |
| CIBC Private Wealth Group LLC | 0.00% | New | 5,000 | $63K |
| Bank of America Corp. | 0.00% | Add +200.2% | 3,990 | $50K |
| Rockefeller Capital Management L.P. | 0.00% | New | 700 | $9K |
| Wells Fargo & Company | 0.00% | New | 300 | $4K |
"% of holder's portfolio" is BBOT's weight in each manager's 13F, not the share of Bridgebio Oncology Therapeut the manager owns.